Leaflet RALOXA 60mg film-coated tablets
Indicated for: osteoporosis
Route of administration: oral
Substance: raloxifene (selective estrogen receptor modulator)
ATC: G03XC01 (Genito urinary system and sex hormones | Other sex hormones and modulators of the genital system | Selective estrogen receptor modulators)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Raloxifene is a medication used for the prevention and treatment of osteoporosis in postmenopausal women. It belongs to the class of selective estrogen receptor modulators (SERMs) and works by maintaining bone density and reducing the risk of fractures.
The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to follow the prescribed dosage and combine the treatment with adequate calcium and vitamin D intake.
Side effects may include hot flashes, muscle cramps, swelling, or flu-like symptoms. In rare cases, severe adverse effects such as deep vein thrombosis or pulmonary embolism may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as clotting disorders, to ensure the safe use of raloxifene.
General data about RALOXA 60mg
- Substance: raloxifene
- Date of latest medicines list: 01-07-2013
- Product code: W56007038
- Concentration: 60mg
- Pharmaceutical form: film-coated tablets
- Quantity: 70
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.